An analogy between the evolution of drug resistance in bacterial communities and malignant tissues
- 21 April 2011
- journal article
- research article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 11 (5), 375-382
- https://doi.org/10.1038/nrc3039
Abstract
There seem to be several overlapping processes that induce resistance to antibiotics for bacteria and chemotherapy for tumour cells. This Perspective discusses how our understanding of bacterial resistance to antibiotics might inform our understanding of the resistance of tumours to therapy. Cancer cells rapidly evolve drug resistance through somatic evolution and, in order to continue growth in the metastatic phase, violate the organism-wide consensus of regulated growth and beneficial communal interactions. We suggest that there is a fundamental mechanistic connection between the rapid evolution of resistance to chemotherapy in cellular communities within malignant tissues and the rapid evolution of antibiotic resistance in bacterial communities. We propose that this evolution is the result of a programmed and collective stress response performed by interacting cells, and that, given this fundamental connection, studying bacterial communities can provide deeper insights into the dynamics of adaptation and the evolution of cells within tumours.Keywords
This publication has 91 references indexed in Scilit:
- Large-scale in silico modeling of metabolic interactions between cell types in the human brainNature Biotechnology, 2010
- Bacterial charity work leads to population-wide resistanceNature, 2010
- Purified human BRCA2 stimulates RAD51-mediated recombinationNature, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Mutational robustness can facilitate adaptationNature, 2010
- Tumor Self-Seeding by Circulating Cancer CellsCell, 2009
- Reconstruction of biochemical networks in microorganismsNature Reviews Microbiology, 2008
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- The Hallmarks of CancerCell, 2000